Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
-
New depression pill begins first human safety tests
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing a new tablet called LY03021 for depression. Researchers are checking how safe it is and how the body processes it in 98 healthy volunteers. They're also seeing if taking the pill with food makes a difference in how it works.
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for IVF: testing drug to prevent early ovulation
Disease control OngoingThis study is testing different doses of an experimental medication called LY01021 to help control the timing of ovulation during fertility treatments like IVF. Researchers want to see which dose works best to prevent eggs from releasing too early while being safe for patients. T…
Phase: PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
Scientists test if meals change how body handles new mental health pill
Knowledge-focused OngoingThis early-stage study aims to understand how eating food affects the way the body absorbs and processes a new extended-release medication (LY03020) being developed for schizophrenia and Alzheimer's disease psychosis. It involves 16 healthy adult volunteers who will take a single…
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC